Drug Trial Radar · NCT01151540
A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
Last checked: Nov 19, 2026Latest source record: Mar 11, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Nov 2010
Primary completion
Aug 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Eisai Co., Ltd.Eisai
- Sponsor type
- Industry
- First posted
- Jun 28, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 4 years, up to 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the safety of long term administration of E2080 in the patients with Lennox-Gastaut syndrome who completed the E2080-J081-304 Study.
Conditions
- Lennox-Gastaut Syndrome
Interventions
RufinamideDrug
The target dosage is approximately 45 mg/kg/day, taken orally twice a day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events as a Measure of Safety and Tolerability of RufinamideTime frame: From date of first dose up to 30 days after the last dose of study treatment, up to approximately 2 years 10 months
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Okayama, Japan
Site not named
Nagoya, Aichi-ken, Japan
Site not named
Matsuyama, Ehime, Japan
Site not named
Fukuoka, Fukuoka, Japan
Site not named
Hiroshima, Hiroshima, Japan
Site not named
Sapporo, Hokkaido, Japan
Site not named
Kobe, Hyōgo, Japan
Site not named
Yokohama, Kanagawa, Japan
Site not named
Goshi^shi, Kumamoto, Japan
Site not named
Iwanuma-shi, Miyagi, Japan
Site not named
Ōmura, Nagasaki, Japan
Site not named
Nara, Nara, Japan
Site not named
Niigata, Niigata, Japan
Site not named
Yufu-shi, Oita Prefecture, Japan
Site not named
Neyagawa, Osaka, Japan
Site not named
Osaka, Osaka, Japan
Site not named
Suita-shi, Osaka, Japan
Site not named
Moriyama-shi, Shiga, Japan
Site not named
Shizuoka, Shizuoka, Japan
Site not named
Kodaira, Tokyo, Japan
Site not named
Kokubunji-shi, Tokyo, Japan
Site not named
Shinjuku, Tokyo, Japan
Site not named
Toyoma-shi, Toyama, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.